PHASE-XS is a self-service, AI-powered clinical intelligence platform for pharma and biotech teams. It provides direct access to structured clinical trial data and analysis, particularly across areas such as oncology and biologics. Users can analyze trial data by therapeutic category, geography, phase, and biologic type across every country the platform covers.
The platform brings clinical trial and drug development data together in one place — an information bank drawn from thousands of sources and thousands of primary research interviews — so teams can access and analyze it without stitching registries together by hand.
PHASE-XS tracks drug development from early-stage trials through approval, pricing, and post-market activity — standardized across all 17 countries covered.
Query the full trial corpus in natural language and surface the molecules, sponsors, and studies that matter.
Slice coverage by therapeutic category, geography, phase, and biologic type across every country tracked.
Break down pipelines by development stage, from Early Phase 1 through Phase 4 and post-market activity.
Compare sponsor activity and pipeline composition to understand who is moving where, and how fast.
Map the competitive landscape across indications, technologies, and approval timelines.
Filter, sort, and export to Excel or CSV — or integrate directly through the enterprise API.
Ten categories of structured fields, standardized and continuously validated across every trial in the dataset.
We envision a future where clinical intelligence is easier to access, understand, and use. Our vision is to make PHASE-XS a trusted intelligence platform for clinical research — delivering actionable insights across newly developed molecules, indications, and therapeutic areas, and putting that information to work in business development, regulatory, medical, and pipeline planning for pharma, biotech, and life sciences.
PHASE-XS aims to help teams identify changes in the competitive landscape, evaluate opportunities, and make decisions with more timely information.
Making clinical trial intelligence faster to access, easier to interpret, and genuinely useful for pharma, biotech, and life sciences teams.
Bringing together clinical trial information from established registries and continuously validating key data points — trial identification, timelines, patient eligibility, therapeutic classification, interventions, sponsor and regulatory status, and outcomes.
Tracking molecules from early-phase development through approval, pricing, and post-market activity, with data standardized across the 17 countries covered by the platform.
Helping teams monitor sponsor activity, therapeutic-area developments, and pipeline changes through AI-powered search, phase-level analysis, and competitive landscape mapping.
Providing tools for enrollment forecasting, adherence tracking, and pricing intelligence through a self-service dashboard or enterprise API — no long-term contract, onboarding in under one business day.
PHASE-XS is a venture of Coherent Market Insights ↗, a data advisory and business consulting firm holding ISO 9001:2015 and ISO 27001:2022 certifications, an ESOMAR membership, and D-U-N-S registration 860519526. The platform inherits CMI's research infrastructure, certification standards, and global primary-research network.
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
860519526
9001:2015
27001:2022
Recognized Excellence! Coherent Market Insights' accolades reflect our innovation, growth, and impact across the market research and consulting industry.
Ready to accelerate your clinical research decisions?
Contact Us